In recent weeks, several media outlets have been reporting on the cases of many women who have become pregnant unexpectedly, even under adverse conditions (with a diagnosis of infertility).
The media point out a common denominator in these cases: the pregnant women were taking anti-GLP1 drugs, better known asOzempic, Wegovy o Mounjaro. Esta medicación, cuyo principio activo es la semaglutida, nació para el tratamiento de la diabetes, y ha demostrado tener un impacto positivo en los procesos de adelgazamiento de personas con obesidad.
The hasty conclusion reached by some sources is that the surge in surprise pregnancies (there is even talk of “Ozempic babies”) is due to the fact that these drugs have an almost miraculous effect on female fertility. Well, we regret to report that this is not the case.
As is known, one of the consequences of having a high body mass index (BMI) in women is fertility problems, with the added risk of developing polycystic ovary syndrome (PCOS) which leads to irregular menstruation.
What is observed in these cases of surprise pregnancies is, simply, that when those women with polycystic ovary syndrome who were taking these drugs to lose weight have lost weight, their hormonal cycle has been restored, and the infertility problems resulting from being overweight have disappeared.
In cases of pregnancies in women taking the contraceptive pill, recent studies suggest that drugs such as Ozempic could cause poor absorption of the pill.
In any case, we remind you that, as indicated in the leaflet of these medications, they are not recommended during pregnancy or breastfeeding. Therefore, if you are aware of a pregnancy while using this medication, you should seek medical advice as soon as possible.